GlycoMimetics, Inc.
Panjang

5 Hot Biotechs to Hold Over The Weekend

817
My Post-FDA Over-The-Weekend Watchlist:
GLYC
OONCT
ONCY
PPIRS
AGEN

All of these biotechs have phase one cancer treatment clinical-trial data releases this weekend. Based on my research, these are the ones that I think are most likely to release good data. Since they are all in phase one, it is likely that we see a gap up on Monday and a solid downtrend from there. Like and follow for more biotech ideas like this :) Happy Trading!

[I]Remember that these are biotech stocks and there are no guarantees in this sector. Proceed with caution![/I]

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.